M&G (Lux) Better Health Solutions Fund C Fonds
11,07
EUR
+0,01
EUR
+0,07
%
NAV
Werbung
Anlageziel
The Fund has two aims: Financial objective: to provide a higher total return (capital growth and income) than that of the global equity market over any five-year period; and Impact objective: to invest in companies that deliver solutions to address better health and well-being. The Fund invests at least 80% of its Net Asset Value in the equity securities and equity related instruments of companies across any sector and market capitalisation that are domiciled, incorporated or listed in any developed market. The Fund has a concentrated portfolio of usually fewer than 40 companies.
Stammdaten
Name | M&G (Lux) Better Health Solutions Fund EUR C Acc Fonds |
ISIN | LU2496701116 |
WKN | A3DRAN |
Fondsgesellschaft | M&G Luxembourg S.A. |
Benchmark | MSCI World |
Ausschüttungsart | Thesaurierend |
Manager | |
Domizil | Luxembourg |
Fondskategorie | Aktien |
Auflagedatum | 02.03.2023 |
Geschäftsjahr | 31.03. |
VL-fähig? | Nein |
Depotbank | State Street Bank International GmbH, Luxembourg Branch |
Zahlstelle | |
Riester Fonds | Nein |
Basisdaten
Auflagedatum | 02.03.2023 |
Depotbank | State Street Bank International GmbH, Luxembourg Branch |
Zahlstelle | |
Domizil | Luxembourg |
Geschäftsjahr | 31.03. |
Aktuelle Daten
Morningstar Rating | |
Aktueller Rücknahmepreis | 11,07 |
Anzahl Fonds der Kategorie | 788 |
Volumen der Tranche | 11.474,33 EUR |
Fondsvolumen | 16,06 Mio. EUR |
Total Expense Ratio (TER) | 0,96 |
Gebühren
Laufende Kosten | 1,01% |
Total Expense Ratio (Verwaltungsgebühren & sonst. Kosten) | 0,96% |
Transaktionskosten | 0,05% |
Depotbankgebühr | - |
Managementgebühr | 0,75% |
Rücknahmegebühr | - |
Ausgabeaufschlag | 1,25% |
Performancedaten
Veränderung Vortag | 0,01 |
WE seit Jahresbeginn | 6,89% |